Risk of Diabetes Following COVID-19: Translating Evidence Into Clinical and Public Health Actions

Francesco Zaccardi^{1

2}, Kamlesh Khunti^{1

2}

Affiliations

¹ Leicester Real World Evidence Unit, Diabetes Research Centre, University of Leicester, Leicester LE5 4PW, UK.
² National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care-East Midlands, University of Leicester, Leicester LE5 4PW, UK.

Comment

Francesco Zaccardi et al. J Clin Endocrinol Metab. 2022.

. 2022 Sep 28;107(10):e4248-e4249.

doi: 10.1210/clinem/dgac384.

Francesco Zaccardi^{1

2}, Kamlesh Khunti^{1

2}

¹ Leicester Real World Evidence Unit, Diabetes Research Centre, University of Leicester, Leicester LE5 4PW, UK.
² National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care-East Midlands, University of Leicester, Leicester LE5 4PW, UK.

No abstract available

Comment on

Risks and burdens of incident diabetes in long COVID: a cohort study.
Xie Y, Al-Aly Z. Xie Y, et al. Lancet Diabetes Endocrinol. 2022 May;10(5):311-321. doi: 10.1016/S2213-8587(22)00044-4. Epub 2022 Mar 21. Lancet Diabetes Endocrinol. 2022. PMID: 35325624 Free PMC article.

1. Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV; et al.. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102-e107. - PMC - PubMed
1. Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. 2022;10(5):311-321. - PMC - PubMed
1. Zaccardi F, Davies MJ, Khunti K. The present and future scope of real-world evidence research in diabetes: what questions can and cannot be answered and what might be possible in the future? Diabetes Obes Metab. 2020;22(S3):21-34. - PubMed
1. Coronavirus (COVID-19) in the UK. https://coronavirus.data.gov.uk/. Accessed June 8, 2022.
1. Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022. doi:10.1038/s41591-022-01840-0 - PMC - PubMed